AVEDON MARCIA J 4

What Happened Marcia J. Avedon, a director of Acuity Inc. (AYI), was granted 546 deferred restricted stock units (DSUs) on January 21, 2026. The Form 4 reports the grant as a derivative award (transaction code A) with an acquisition price of $0.00 on the filing (no cash paid). The DSUs were calculated using an average price of $320.59 (the average of the high and low prices over the five trading days before the grant), implying a notional value of about $175,042 (546 × $320.59). The DSUs convert 1-for-1 to shares when payable.

Key Details

• Transaction date: 2026-01-21; Form filed: 2026-01-23 (timely filing).
• Reported on Form 4 as: Grant/Award (A) — 546 DSUs @ $0.00 (derivative award).
• Valuation basis: $320.59 per share (5-day average) — implied value ≈ $175,042.
• Vesting/payout: DSUs vest in full on the first anniversary of the grant date or at the next annual meeting (if earlier); once vested they are payable upon retirement either in a lump sum or in five annual installments (see footnote).
• Shares owned after transaction: Not disclosed on the Form 4.
• Origin: DSUs resulted from the director’s election to receive a portion of annual director fees in DSUs (deferred compensation), per the company’s omnibus plan.

Context This was a deferred-compensation award to a director, not an open-market purchase or sale of stock. DSUs are a form of deferred equity compensation — they are not immediately tradable shares and do not by themselves indicate a buy or sell sentiment. They will convert to stock (or cash-equivalent installments) only after vesting and the director’s retirement according to the plan terms.